Introduction
The management and the timing of surgery in asymptomatic patients with severe aortic stenosis (AS) remains a matter of concern. In this setting, valve replacement is recommended when the left ventricular ejection fraction (LVEF) is reduced (<50%). However, LVEF is often preserved in severe AS due to adapted LV remodeling to the increased afterload, often leading to late surgical referral. Furthermore, recent studies have showed that irreversible LV myocardial fibrosis may be present even when LVEF 1;2 is preserved.
A recent registry reported that compared to the conventional treatment strategy (i.e. "wait for symptoms"), early surgery in patients with very severe AS was associated with an improved long-term survival by decreasing cardiac mortality 3 . However, surgeons may be reluctant to operate on asymptomatic patients. The risks of aortic valve surgery and late complications of prosthesis need to be balanced against the possible prevention of sudden death and lowering of cardiac mortality. Hence, early elective surgery could be proposed to selected patients with a high risk of rapid LV function deterioration or symptomatic status impairment (i.e. high risk of poor outcome) 4;5 . This strategy requires the identification of accurate markers of poor outcome.
In this regard, the presence of pulmonary hypertension (PHT) in patients with severe AS seems to be associated with a poorer prognosis 6;7 , a higher mortality rate after valve replacement 8 and
represents an independent predictor of hospital mortality and postoperative major adverse cardiovascular and cerebrovascular events 9 . In patients receiving transcatheter aortic valve implantation, PHT was a strong independent predictor of poor outcome, augmenting by 2 the risk of late mortality 10 .
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Methods
We prospectively included consecutive patients with asymptomatic severe AS (n=195), defined as an aortic valve area (AVA) indexed for body size area <0.6cm²/m², and preserved LVEF ( 55%) referred to our laboratory for exercise stress echocardiography. Only patients with a normal exercise stress test (i.e. "truly" asymptomatic patients) were considered for the final analysis of the study, resulting in the exclusion of 45 patients with abnormal exercise response.
The other exclusion criteria were (1) more than mild concomitant valvular heart disease (n=3),
(2) atrial fibrillation (n=2), (3) known pulmonary disease (n=1), (4) inability to perform an exercise test (n=4) and (5) absence of measurable systolic pulmonary arterial pressure (SPAP) at exercise (n=35). The final population was composed of 105 patients (71±9 years, 59% of male).
The collection of baseline demographic and clinical data was standardized and performed at the time of exercise stress echocardiography.
Echocardiographic study
Before exercise stress test, resting comprehensive transthoracic echocardiography was performed using VIVID 7 ultrasound system (General Electric Healthcare, Little Chalfont, UK). All Doppler-echocardiographic recordings were stored on a dedicated workstation for off-line subsequent analysis. For each measurement, at least two cardiac cycles were averaged.
Continuous wave Doppler was used to measure the aortic transvalvular maximal velocities; peak and mean gradients were calculated using the simplified Bernoulli equation ( P=4v², where v is analysis of the study, resulting in the exclusion of 45 patients with abnormal exe er r rcis is se re re resp sp spon on onse se.
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The collection on n o o of f ba ba base se seli line n n d d dem em emog og ogra ra r ph ph p ic ic c a a and nd nd c c cli li l ni ni nica ca cal l da d ta ta ta w w was as as s s sta ta tand nd ndar ar a di di d ze ze zed d d an an a d d d pe pe perf rf rfor or orme m d at the maximal aortic velocity in m/s). The LV stroke volume was calculated by multiplying the LV outflow tract area by the LV outflow tract velocity-time integral measured by pulsed-wave Doppler. AVA was calculated using the continuity equation. The bi-apical Simpson disk method was applied to quantify LV end-diastolic and end-systolic volumes and EF. In addition to this conventional evaluation of LV systolic function, 2D speckle tracking analysis (2D strain) was performed to quantify global longitudinal myocardial deformation as previously described 5;11 .
Briefly, 2D strain is a non-Doppler-based method using standard 2D images with a frame rate acquisition >60Hz. By tracing the endocardial borders on an end-systolic frame, the software automatically tracked the contour on the subsequent frames. Adequate tracking was verified in real-time and was manually corrected, when necessary. The global longitudinal deformation strain (GLS) represents the average of the segment strains from the conventional apical 4-, 3-and 2-chamber views. Left atrial area was obtained by planimetry of an end-systolic frame from the apical 4-chamber view. Peak E-and A-wave velocities of the mitral inflow were measured using pulsed wave Doppler. Tissue Doppler imaging was applied for the measurement of e'-wave. The average of septal and lateral mitral annulus Ea-wave velocities was used for the calculation of the E/e' ratio.
SPAP was derived from the regurgitant jet of tricuspid regurgitation using systolic transtricuspid pressure gradient and the addition of 10 mm Hg for right atrial pressure as previously performed 12;13 . Resting PHT and exercise PHT were defined as SPAP >50 and >60 mm Hg, respectively. Right atrial pressure was assumed to be constant from rest to exercise.
Exercise protocol
A symptom-limited graded maximum bicycle exercise test was performed in the semi-supine position on a tilt-table. After an initial workload of 25W maintained for 2 min, the workload was 
Event-free survival
Follow-up information was obtained every 6 to 12 months from standardized interviews with the d pa ati ti ien en ents ts ts, th th thei ei eir r r ph h hys ys ysic icians or, if necessary, with n n nex ex e t t of kin, accord d din i g to to o g g guidelines 14; 15 . The prim m mary outcom ome e e v va vari ri iab able le le w was as as t the he e t tim im i e e t t to oc cc ccu urre e en nc ce of of of t the he e f f fir irst st t c com omp pos site te e en nd ndpo po oin in nt t Probabilities of event-free survival were obtained by Kaplan-Meier estimates for the 2 groups and then compared by a 2-sided log-rank test.
The impact of exercise PHT on event-free survival was assessed with Cox proportionalhazards models in univariable and multivariable analyses. Variables with a univariable value of p<0.10 were incorporated into the multivariable models. The selection of variables included in the multivariate model was performed with a special care. To avoid colinearity among a subset of several variables measuring the same phenomenon (e.g., AVA, peak gradient, mean gradient),
we entered in the multivariate models the variable that had the strongest association with eventfree survival on univariable analysis. In addition, to assess the accuracy of prediction of cardiac event by each model, we generated the Harrell correspondence index (C-statistic).
Values of p<0.05 were considered significant. All statistical analyses were performed with STATISTICA version 7 (StatSoft Inc, Tulsa, Okla). The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agreed to the manuscript as written.
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Results

Population characteristics
PHT, as previously defined, was significantly more frequent during exercise (55% vs. 6%, p<0.0001), than at rest. Patients with exercise PHT were more frequently male and had significant lower resting heart rate than those with no exercise PHT ( Table 1 ). In addition, all patients with resting PHT (n=6, Table 2 ) also developed exercise PHT (resting PHT prevalence in exercise PHT compared to no exercise PHT group: p=0.027). There was no other significant difference between the 2 groups regarding demographic, clinical or exercise data, as well as risk factors and medications. The maximal exercise capacity reached was 4.8±1.2METs (64±14% of the predicted METs), ranging from 2.3 to 8.6 METs without significant difference between the 2 groups (p=0.12 and p=0.74 for the percentage of predicted METs).
Resting and exercise echocardiography
SPAP significantly increased from rest to exercise (from 38±8 mmHg to 62±16 mmHg, p<0.0001). Patients with exercise PHT had significant higher resting SPAP (p<0.0001, Table 2) and exercise-induced changes in SPAP (Figure 1 , Panel A and B: +14.9±7 mmHg vs. +33.6±10 mmHg, p<0.0001). In patients with exercise PHT, the mean relative change in SPAP was 121±61%. During exercise, SPAP was doubled in 10 patients (21%) without exercise PHT and in 32 patients (56%, p<0.0001) with exercise PHT.
Compared to patients with no exercise PHT, those with exercise PHT (Table 2) had higher resting and exercise indexed LV end-diastolic volume (p=0.045 and p=0.04), and more severe resting and exercise AS severity (peak transaortic gradient: p=0.046 and p=0.008; mean transaortic gradient: p=0.04 and p=0.04), higher exercise e'-wave velocity (p=0.004) and larger exercise indexed LA area (p=0.001). There were also trends for significant higher resting and he predicted METs), ranging from 2.3 to 8.6 METs without significant differenc nc ce be be b tw tw wee ee een n n th th the e 2 groups (p=0.12 and p=0.74 for the percentage of predicted METs).
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Determinants of exercise SPAP and PHT
In simple linear regression, exercise SPAP was significantly correlated with resting SPAP (r=0.57, p<0.0001), heart rate (r=-0. 20 In addition, the best correlation was found between exercise SPAP and exercise-induced changes On multivariable analysis, using logistic regression ( 
Cardiac event-free survival
The follow-up was complete in all patients (100%). The mean follow-up time was 19±11 months (median: 16 months, range: 2 to 48 months). During follow-up, 56 patients (53%) fulfilled the predefined end-point resulting in event-free survival of 72±4%, 50±5% and 34±6% at 1-, 2-and 3-year follow-up, respectively. There were 7 cardiovascular deaths during the follow-up (3 sudden deaths and 4 deaths following heart failure hospitalization). Of note, the 7 patients who died had developed exercise PHT (12%) but only 1 had resting PHT (p=0.014). The remaining cardiac events were aortic valve replacement dictated by the onset of symptoms (n=49). The main indication for surgery was the occurrence of syncope (n=4), angina (n=6), dyspnea (n=38) and significant arrhythmia (n=1).
During the follow-up, among the 6 patients with resting PHT, 1 died, 2 underwent an AVR and 3 remained free of event.
The raw rate of cardiac event (number of patients with an event divided by total number of patients in each group) was significantly higher in patients with exercise PHT (n=39 vs. n=17, 67% vs. 36%, p=0.0015).
Patients with exercise PHT had lower cardiac event-free survival (1-year: 65±6 vs.
81±6%, 2-year: 43±7 vs. 59±8%, 3-year: 22±7 vs. 55±9%, p=0.014; Figure 2) . In univariable analysis, exercise PHT was associated with 2-fold increase in cardiac events compared to patients without exercise PHT (p=0.017, Resting PHT (n=6) was not associated with reduced cardiac event-free survival (p=0.37). exercise-induced change in mean transaortic pressure gradient was also an independent predictor of events (p=0.043).
Using receiver-operating characteristic curve analysis, exercise SPAP had a good accuracy to predict cardiac events (area under the curve: 0.69). Of interest, the best cut-off value to predict cardiac events was exercise SPAP>60mmHg: sensitivity= 70%, specificity= 62%, positive predictive value= 67% and negative predictive value=64%.
In addition, to assess whether exercise SPAP was more accurate than resting SPAP to adjustment including resting echocardiographic data, exercise PHT remained inde de depe pe end nd den n entl tl tly y y af fte te ter r ad ad adju ju just st tme me m nt nt fo or or a ag ge ge, , , se sex, x, res es esti ti ting ng ng e ech ch choc oc oca a ardi di diog og ogra raph ph p ic ic i d d dat at ata a an an and d d ex ex exer er e c c cise se e-i -in nd ndu uc uced ed d c c cha ha ang ng ges es i i in mean transva alv lv lvul ul u ar ar ar p p pre re ess ss s ur r re e e gr g g ad ad adie ie i nt nt nt, ex ex exer er erci ci cise se se PH PH PHT T T re re r ma ma main in ined ed ed a a an n n in n nde de depe pe pend nd nden en e t pr pr pred ed edic ic icto to t r of high predict cardiac event, we generated the C-statistic for each model. The C-statistics were systematically higher with exercise SPAP than resting SPAP in univariate, age-and sex-adjusted or age-, sex-and resting echocardiographic data-adjusted models (0.610 vs. 0.515, 0.613 vs.
0.557, and 0.664 vs. 0.611, respectively).
Incremental prognostic value of exercise PHT over resting AS severity
In the whole multivariate model, peak aortic jet velocity was the strongest resting echocardiographic predictor of outcome (HR=1.02, 95%CI: 1.01-1.03, p<0.0001). Figure 3 shows the incremental value of exercise PHT over markedly elevated peak aortic jet velocity (>4.0m/s) in the prediction of cardiac events. The combination of both high peak aortic jet velocity and exercise PHT resulted in the worse outcome (p=0.008). As compared to the whole cohort, patients with high peak aortic jet velocity and exercise PHT had a 2.4-fold increase in risk of reduced event-free survival (95%CI: 1.4-4.03, p=0.002). Reducing the analysis only to the subset of patients with markedly elevated peak aortic jet velocity resulted in a significant impact of exercise PHT on outcome (HR=2.4, 95%CI: 1.1-5.2, p=0.014). Of note, patients with exercise PHT but without markedly elevated peak aortic jet velocity had similar 2-year event-free survival (54±10% vs. 56±11%, p=0.77) than those with markedly elevated peak aortic jet velocity but without exercise PHT.
Furthermore, the 7 deaths occurring during the follow-up were patients with both markedly elevated peak aortic jet velocity and exercise PHT (p=0.001).
Discussion
The main findings of the present study show that (1) exercise PHT (i.e. exercise SPAP>60mmHg) is a frequent condition (55% of the cohort) in patients with asymptomatic velocity and exercise PHT resulted in the worse outcome (p=0.008). As compared ed d t t to o th th the e e wh wh whol ole e cohort, patients with high peak aortic jet velocity and exercise PHT had a 2.4-fold increase in isk sk k o of f f re redu du duce ce ed ev ev eve en ent-free survival (95%CI: 1.4-4 4 4.0 03, p=0.002). Re Re R du uci ci cin ng ng the analysis only to the u ubs bs set e of patien ent ts ts w w wit ith h h ma ma mark rk rked ed edly ly e e ele le eva va ate ted pe e ea ak k ao o ort ti ic j jet et t v ve e elo oc ocit ity y y r r resu sult lt l e ed d i in n n a a a si sign gn gnif if ific ica an ant t t im im impa a act of f f e e exe xe erc rc r is ise e e PH PH PHT T on n n o ou u utc co come me ( ( (H H HR= R= R=2. 2. 2 4, 4, , 9 9 95% 5% 5%CI I I: : : 1. 1. .1---5. 5 2, 2, 2 p p p=0 =0 =0.0 0 014 14 14). ) ) O O Of f n no not te te, , pa pa pati ti tien en nts ts ts wit it th h ex exe e erc ci cise s PHT but with thou ou out t ma ma mark rk ked ed e ly y y e ele le l va va vat t ted ed ed p pea ea eak k k ao ao aort rt tic ic ic j j jet et et ve ve v lo o oci ci c ty ty ty h h had ad ad s s sim m mil il ilar ar ar 2 2 2-y -y yea ea e r r r ev ev even en ent-t-t fr f ee severe AS and preserved LVEF, (2) the independent determinants of exercise PHT are male gender, resting SPAP and exercise parameters of diastolic burden (exercise indexed LV enddiastolic volume, exercise e'-wave velocity and exercise induced changes in indexed LA area), (3) exercise PHT is associated with alarming rate of cardiac death (12%) and with significant reduced cardiac event-free survival, (4) independent of age, sex, resting echocardiographic data and exercise-induced changes in mean transaortic pressure gradient, exercise PHT doubles the risk of cardiac events and (5) exercise PHT had an incremental prognostic value as compared to resting AS severity parameter. Conversely, although resting elevated SPAP may affect the clinical outcome, its prognostic value was weak in our study.
Pulmonary arterial hypertension in aortic stenosis
The prevalence of PHT varies considerably over studies according to patient selection criteria and the threshold used to define PHT. Overall, a SPAP >50mmHg is found in 15-30% of patients with severe AS [16] [17] [18] and recently, severe SPAP (>60mmHg) was reported in 19% of a large cohort of 626 AS patients 19 .
However, no study, to the best of our knowledge, reported the prevalence of PHT in "truly" asymptomatic patients. In our cohort, a SPAP >50mmHg was rare and only identified in 6 patients (6%) suggesting that the impact of severe AS on LV diastolic function 20 and LA geometry and function 21;22 may be generally well counterbalanced by LA compliance and/or pulmonary vascular resistance. Of interest, these patients with resting PHT were particularly old, had a very severe AS, and half of them experienced cardiac events (including 1 death and 2 AVR), suggesting the poor outcome of this subset.
In contrast, a recent study has shown that PHT is frequent in surgery-referred patients with LV dysfunction and is independently associated with LA function impairment 23 .
The prevalence of PHT varies considerably over studies according to patient selection criteria an nd d d th th the e e th th thre re resh sh shol ld d d u us used to define PHT. Overall, a a a S SP P PAP >50mmH Hg g g is f f fou ou oun nd in 15-30% of patients w with h h severe AS AS 16-1 1 1 18 a and nd nd r rec ec ecen en ent tl tly, y, s s se ev eve er re e SP PAP AP AP (> >6 >60m 0mmH mH m g g g) w was as s r rep epor or rte ted d in in n 1 1 19% 9% % o of f f a a la ar rg rge e co oho ho h rt rt rt o of f 62 62 626 6 6 AS AS S p p pat ati ie en nt ts s 19 .
Howe weve ve ver, r, n n no o o st st tud ud u y, y, , t to o o th h he e e be be est s o o of f ou ou our r r kn kn know ow owle le edg dge, e, e, r r rep ep epor or orte te ted d th th the e e pr pr prev ev eval al a en en nce ce ce o o of f f PH P P T in
The potential impact on outcome of PHT in patients with AS is also a source of debate. In 1979, McHenry et al. 7 showed that PHT could be considered as a harbinger for sudden death and clinical deterioration. More recently, PHT in severe AS was also associated with a dismal prognosis under conservative management 24;25 . Nevertheless, PHT may frequently and rapidly be abolished following aortic valve replacement [24] [25] [26] leading to a more favorable long-term outcome 27 .
Exercise pulmonary hypertension in aortic stenosis.
Exercise PHT was significantly more frequent (55%) than resting PHT (6%) in our cohort. This entity is characterized by lower resting heart rate and higher both rest and peak exercise indexed LV end-diastolic volume. During exercise, whereas some patients with no exercise PHT may only have mild increase in SPAP (Figure 1, Panel A) , the vast majority of those with exercise PHT (Figure 1, Panel B) experienced a marked rise in SPAP. This phenomenon is essentially determined by the level of exercise e'-wave velocity, the exercise indexed LV end-diastolic volume and the exercise-induced changes in indexed LA area.
In AS, the chronically increased afterload results in progressive LV remodelling and myocardial hypertrophy. Although the increase in LV wall thickness is a compensatory mechanism that reduces systolic wall stress, it can result in impaired LV relaxation, reduced LV compliance and increased metabolic demands. The ability of the LV to adequately fill under normal pressures is thus altered and the LV diastolic pressure increases. As a result, LA slowly expands and becomes dysfunctional and less compliant, making it impossible to limit the transmission to the pulmonary vascular bed of any further increase, even minimal, in LV enddiastolic pressure observed during exercise. Furthermore, any degree of LV diastolic dysfunction (relaxation abnormality) and increased LV filling pressure at rest and/or at exercise can be LV end-diastolic volume. During exercise, whereas some patients with no exerci cis se P PHT HT HT m m may ay ay only have mild increase in SPAP (Figure 1, Panel A) , the vast majority of those with exercise f 
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Clinical implication
Our results are the first to demonstrate that the measurement of SPAP during exercise echocardiography may improve risk stratification of asymptomatic severe AS. Indeed, patients who experienced exercise PHT (SPAP>60mmHg) multiplied by 2 the risk of cardiac events, even after adjustment for demographic and resting and exercise echocardiographic data. Among the 7 cardiovascular-related deaths occurring during follow-up, only 1 patient had resting PHT, but all of them had developed exercise PHT. Of interest, our data show that resting elevated SPAP is not independently associated with reduced cardiac event-free survival in "truly" asymptomatic patients with severe AS.
Hence, these results strongly emphasize the usefulness of exercise stress echocardiography in this clinical situation. Exercise PHT also had incremental prognostic value as compared to AS severity parameters (i.e. aortic jet velocity). Indeed, in patients with markedly elevated aortic jet velocity, those with exercise PHT exhibited a significant lower cardiac eventfree survival (Figure 3) as compared to the others, resulting in poorer outcome. Furthermore,
Our results are the first to demonstrate that the measurement of SPAP during exercise These patients are probably more subject to rapidly develop symptoms and seem to be at higher risk of cardiac-related death. Consequently, the use of exercise stress echocardiography in asymptomatic patients with severe AS could be recommended. At peak exercise, the measurement of both mean transaortic pressure gradient and SPAP, which are technically easy, rapid and with good reproducibility 13;29-32 , may improve the management of such patients.
Indeed, the high rate of cardiac-related death observed in patients with exercise PHT (12%), despite normal exercise test, should encourage prompt surgery, which is, in asymptomatic patients, associated with very low operative mortality 3 and low prosthesis-related complication rate. Conversely, patients with no exercise PHT and no marked increase in mean transaortic gradient can be followed-up safely.
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Limitations
Apparent non-significant results may be related to the relatively small sample size of the study.
Specifically, the absence of relationship between maximal exercise capacity parameters and cardiac event-free survival could be mainly due to a type II error. Nevertheless, this limitation does not affect the validity of the main result of the study, which is the demonstration that exercise PHT may have an incremental prognostic value in patients with asymptomatic severe AS.
Despite careful assessment, the evaluation of the occurrence of symptoms at a low workload during exercise remains subjective. Hence, while rare, it is possible that some patients with symptoms during exertion were included in the final population.
As in our previous studies 13;33 , the right atrial pressure was estimated at 10 mmHg both at rest and during exercise. Hence, we may have missed the potential influence of exercise-induced changes in right atrial pressure. Nevertheless, the noninvasive evaluation of right atrial pressure during exercise (i.e., when venous compliance is known to decrease) with noninvasive methods such as Doppler echocardiography remains difficult, is probably subject to low accuracy, and is not validated. Moreover, right atrial pressure is frequently assumed to be 5 mmHg in normal subjects 30 and 10 mmHg in patients with valvular disease 12 .
The absence of evaluation of the presence and extent of coronary artery disease in patients not referred to surgery is also a limitation of this report. However, these patients have, by definition, no resting symptoms, normal LVEF and exercise test, suggesting that they are "truly" asymptomatic. In this context, coronary angiography is not recommended and the rate of significant coronary artery disease in our population is probably low.
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Conclusion
In asymptomatic patients with severe AS, the main determinants of exercise PHT are male gender, resting SPAP and exercise parameters of diastolic burden. Exercise PHT is associated with 2-fold increased risk of cardiac events and provides incremental prognostic value, independently of demographic, resting echocardiographic data and exercise-induced changes in mean transaortic pressure gradient. These results support the use of exercise stress echocardiography in asymptomatic AS. 
